Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Esther Veronika Wenzel1, Kilian Johannes Carl Zilkens1

  • 1Abcalis GmbH, Inhoffenstraße 7, D-38124 Braunschweig, Deutschland.

Biospektrum : Zeitschrift Der Gesellschaft Fur Biologishe Chemie (GBCH) Und Der Vereinigung Fur Allgemeine Und Angewandte Mikrobiologie (VAAM)
|April 4, 2022
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The landscape of antibody production systems: recombinant expression for research, diagnostics and therapy.

Frontiers in bioengineering and biotechnology·2026
Same author

Fetal bovine serum: how to leave it behind in the pursuit of more reliable science.

Frontiers in toxicology·2025
Same author

Antibody Selection in Solution Using Magnetic Beads.

Methods in molecular biology (Clifton, N.J.)·2023
Same author

Baculovirus-Free SARS-CoV-2 Virus-like Particle Production in Insect Cells for Rapid Neutralization Assessment.

Viruses·2022
Same author

Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant.

Nature communications·2022
Same author

<i>In vitro</i> evolution of <i>myc-</i>tag antibodies: in-depth specificity and affinity analysis of Myc1-9E10 and Hyper-Myc.

Biological chemistry·2022
Same journal

Biospektrum : Zeitschrift der Gesellschaft fur Biologishe Chemie (GBCH) und der Vereinigung fur Allgemeine und Angewandte Mikrobiologie (VAAM)·2023
Same journal

Biospektrum : Zeitschrift der Gesellschaft fur Biologishe Chemie (GBCH) und der Vereinigung fur Allgemeine und Angewandte Mikrobiologie (VAAM)·2023
Same journal

Biospektrum : Zeitschrift der Gesellschaft fur Biologishe Chemie (GBCH) und der Vereinigung fur Allgemeine und Angewandte Mikrobiologie (VAAM)·2023
Same journal

Biospektrum : Zeitschrift der Gesellschaft fur Biologishe Chemie (GBCH) und der Vereinigung fur Allgemeine und Angewandte Mikrobiologie (VAAM)·2023
Same journal

Biospektrum : Zeitschrift der Gesellschaft fur Biologishe Chemie (GBCH) und der Vereinigung fur Allgemeine und Angewandte Mikrobiologie (VAAM)·2023
Same journal

Biospektrum : Zeitschrift der Gesellschaft fur Biologishe Chemie (GBCH) und der Vereinigung fur Allgemeine und Angewandte Mikrobiologie (VAAM)·2023
See all related articles

Animal-free recombinant antibodies offer sustainable alternatives to traditional animal-based methods. This study details generating an animal-free antibody for SARS-CoV-2 spike protein, promoting reliable research.

Area of Science:

  • Biotechnology
  • Immunology
  • Molecular Biology

Context:

  • Traditional antibody production relies heavily on laboratory animals, raising ethical and reproducibility concerns.
  • Readily available alternative technologies exist but are underutilized in antibody generation.
  • The need for sustainable and reliable methods in biological research is increasing.

Purpose:

  • To introduce the concept and advantages of animal-free recombinant antibodies.
  • To describe the successful generation of an animal-free antibody targeting the SARS-CoV-2 spike protein.
  • To advocate for the adoption of sustainable, animal-free antibody technologies.

Summary:

  • This work presents animal-free recombinant antibodies as a viable alternative to animal-derived antibodies.

Related Experiment Videos

  • A specific animal-free antibody was successfully generated against the SARS-CoV-2 spike protein.
  • The study highlights the potential for improved data reliability and reproducibility using these advanced methods.

    • Impact:

    • Promotes the adoption of ethical and sustainable practices in antibody production.
    • Offers a pathway to more consistent and reproducible results in research and diagnostics.
    • Contributes to the development of next-generation diagnostic and therapeutic tools for infectious diseases like COVID-19.